Related Experiment Videos
Albendazole therapy for a recurrent orbital hydatid cyst
1Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India.
Indian Journal of Ophthalmology
|December 16, 2000
Summary
Ophthalmologists previously found treating orbital hydatid cysts challenging. Recent clinical trials show mebendazole and albendazole offer effective chemotherapy options for hydatid disease.
Area of Science:
- Ophthalmology
- Parasitology
- Pharmacology
Background:
- Multiloculated hydatid cysts in the orbit present significant treatment challenges.
- Surgical intervention for orbital hydatid cysts is complex and carries risks.
Observation:
- Benzimidazole compounds, specifically mebendazole and albendazole, have emerged as potential chemotherapeutic agents.
- Clinical testing over the past decade has evaluated their efficacy in hydatid disease.
Findings:
- Mebendazole and albendazole demonstrate clinical utility in managing hydatid disease.
- These agents offer a less invasive treatment modality compared to surgery for orbital cysts.
Implications:
- The findings suggest a shift towards medical management for orbital hydatid cysts.
- This could improve patient outcomes and reduce the morbidity associated with surgical treatments.
- Further research may establish benzimidazole chemotherapy as a standard treatment protocol.